Context TherapeuticsCNTX
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 42 institutions reported holding Context Therapeutics Inc. (CNTX) in their 13F filings, down 10 from Q4 2024. 2 opened new positions and 12 sold out. The largest holders were MPM Bioimpact LLC ($9.0M), Avidity Partners Management LP ($4.6M) and Nextech Invest Ltd. ($4.5M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Context Therapeutics Inc.
- CUSIP
- 21077P108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $19K |
| Exits | 12 | $598K |
All 13F filers, Q4 2024 → Q1 2025: 1,293,083 shares bought and 2,684,149 shares sold, net −1,391,066 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 42 holders
| MPM Bioimpact LLC | 1.55% | No change | 14,705,882 | $9.0M |
| Avidity Partners Management LP | 0.94% | No change | 7,477,200 | $4.6M |
| Nextech Invest Ltd. | 1.06% | — | 7,419,355 | $4.5M |
| Deep Track Capital, LP | 0.15% | No change | 7,419,355 | $4.5M |
| Blue Owl Capital Holdings LP | 1.46% | Add +15.9% | 7,367,906 | $4.5M |
| Great Point Partners LLC | 1.56% | No change | 4,683,711 | $2.9M |
| Franklin Resources Inc. | 0.00% | No change | 4,003,380 | $2.5M |
| Vanguard Group Inc. | 0.00% | Reduce -0.1% | 3,253,467 | $2.0M |
| Blackstone Inc. | 0.01% | No change | 2,440,330 | $1.5M |
| Nantahala Capital Management, LLC | 0.10% | No change | 1,935,484 | $1.2M |
| Alyeska Investment Group, L.P. | 0.00% | No change | 1,663,355 | $1.0M |
| Woodline Partners LP | 0.01% | Reduce -0.0% | 1,361,188 | $833K |
| Sio Capital Management, LLC | 0.25% | No change | 1,328,352 | $813K |
| Ally Bridge Group (NY) LLC | 0.64% | Reduce -26.6% | 1,157,448 | $708K |
| Allostery Investments LP | 0.84% | No change | 950,166 | $582K |
| BlackRock, Inc. | 0.00% | Reduce -7.0% | 848,970 | $520K |
| Affinity Asset Advisors, LLC | 0.07% | Reduce -34.9% | 660,589 | $404K |
| Geode Capital Management, LLC | 0.00% | Add +1.7% | 639,219 | $391K |
| Renaissance Technologies | 0.00% | Add +25.7% | 425,500 | $260K |
| ADAR1 Capital Management, LLC | 0.04% | No change | 351,094 | $215K |
| Shay Capital LLC | 0.03% | Add +279.7% | 189,853 | $116K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -46.0% | 174,309 | $107K |
| Walleye Capital LLC | 0.00% | Add +1.6% | 168,960 | $103K |
| State Street Corp. | 0.00% | No change | 152,607 | $93K |
| HighTower Advisors, LLC | 0.00% | No change | 125,852 | $77K |
| Northern Trust Corp. | 0.00% | No change | 113,565 | $70K |
| Velan Capital Investment Management LP | 0.06% | No change | 90,000 | $55K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.00% | Reduce -78.1% | 67,631 | $41K |
| Clear Harbor Asset Management, LLC | 0.00% | No change | 57,804 | $35K |
| Millennium Management | 0.00% | Reduce -72.8% | 48,671 | $30K |
| Landscape Capital Management, L.L.C. | 0.00% | Reduce -54.2% | 41,216 | $25K |
| Caxton Corp. | 0.22% | No change | 18,403 | $11K |
| XTX Topco Ltd | 0.00% | New | 15,673 | $10K |
| CW Advisors, LLC | 0.00% | New | 15,000 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1324.4% | 13,304 | $8K |
| Cerity Partners LLC | 0.00% | No change | 10,000 | $6K |
| Osaic Holdings, Inc. | 0.00% | Reduce -4.8% | 10,000 | $6K |
| Bank of America Corp. | 0.00% | Reduce -92.9% | 444 | $272 |
| UBS Group AG | 0.00% | Reduce -99.9% | 432 | $264 |
| SBI Securities Co., Ltd. | 0.00% | No change | 113 | $69 |
| Morgan Stanley | 0.00% | Reduce -56.0% | 100 | $61 |
| JPMorgan Chase & Co. | 0.00% | Reduce -51.8% | 80 | $49 |
"% of holder's portfolio" is CNTX's weight in each manager's 13F, not the share of Context Therapeutics Inc. the manager owns.